Skip to Main Content

Author Details

Cathy Corbishley
The Institute of Cancer Research
1977
110
38
PMIDPaper TitleJournal TitlePublished Year
37463104International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial.BJU Int2024
36708693Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.EBioMedicine2023
29105175The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations.Histopathology2018
29928699Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.Clin Transl Radiat Oncol2018
29902261PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer.PLoS One2018
30031830The Prognostic Value of PIK3CA Copy Number Gain in Penile Cancer.Urology2018
29662627Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.Oncotarget2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29604228A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer.BJU Int2018
29559283Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2018
29184776Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity.Transl Androl Urol2017
28239904UICC drops the ball in the 8th edition TNM staging of urological cancers.Histopathology2017
26901676DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes.PLoS One2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25656527Clinicopathological features of carcinoma of the distal penile urethra.Semin Diagn Pathol2015
25662797Glans resurfacing for precancerous and superficially invasive carcinomas of the glans penis: Pathological specimen handling and reporting.Semin Diagn Pathol2015
25156499Should centralized histopathological review in penile cancer be the global standard? A call for the international adoption of penile specialist networks.BJU Int2014
23153743Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution.Eur Urol2013
22011445Clinicopathological and molecular study of penile melanoma.J Clin Pathol2012
23204663Basaloid carcinoma of the prostate: A literature review with case report.Indian J Urol2012
22447920The prognostic value of Ki-67 expression in penile squamous cell carcinoma.J Clin Pathol2012
20575979Nicorandil-induced penile ulcerations: a case series.BJU Int2011
21323963The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma.Histopathology2011
21358652Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle.Kidney Int2011
21407808Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas.PLoS One2011
19493268Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated.BJU Int2010
20800339Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients.Eur Urol2010
19935788Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.Br J Cancer2010
20092961Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.Int J Radiat Oncol Biol Phys2010
19647926Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience.Eur Urol2010
19040532Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.BJU Int2009
19414668Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis.J Clin Oncol2009
19465901HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis.Mod Pathol2009
19168692Dynamic contrast-enhanced MRI for prostate cancer localization.Br J Radiol2009
19095815Sentinel lymph node biopsy using dynamic lymphoscintigraphy combined with ultrasound-guided fine needle aspiration in penile carcinoma.Br J Radiol2009
18762814Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance.Prostate Cancer Prostatic Dis2009
17368710The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study.Eur Urol2008
19096962HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer.Biomarkers2008
18797456Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study.Br J Cancer2008
18540931The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study.BJU Int2008
18489530DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.BJU Int2008
18487387Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens.Br J Radiol2008
18343725Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.Lancet Oncol2008
18165275Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays.J Mol Diagn2008
17488307Penile-preserving surgery for male distal urethral carcinoma.BJU Int2007
17617137Prognostic significance of erythropoietin expression in human renal cell carcinoma.BJU Int2007
17578518Evaluation of dynamic lymphoscintigraphy and sentinel lymph-node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma.BJU Int2007
17687340Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival.Br J Cancer2007
17349734Reconstructive surgery for invasive squamous carcinoma of the glans penis.Eur Urol2007
  • 1 - 50 of 110

Recommended Authors

Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 6
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 5
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 1996
Number of shared co-authors 1
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 6
Elizabeth L Salisbury
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 0
David Clouston
Career Start Year 1995
Number of shared co-authors 6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 7
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 5
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 1
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 1
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 12
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 5
Edward C Jones
University of British Columbia
Career Start Year 1985
Number of shared co-authors 3
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 2
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 16
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 21
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 1
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 4
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 6
John R Srigley
University of Toronto
Career Start Year 1980
Number of shared co-authors 6
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 7
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 3
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 6
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 3
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 15
Michael M Lieber
Mayo Clinic College of Medicine
Career Start Year 1973
Number of shared co-authors 0
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 3
Christer Busch
Uppsala University
Career Start Year 1970
Number of shared co-authors 2

Collaborators

Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 14
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 12
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 9
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 8
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 8
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 6
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 6
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 5
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Co-authored papers 5
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 5
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 5
Douglas F Easton
University of Cambridge
Co-authored papers 4
Christopher J Woodhouse
Royal Marsden NHS Foundation Trust
Co-authored papers 4
Yoav Ben-Shlomo
Co-authored papers 4
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 4
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 3
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers 3
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 3
Peter Van Loo
The Francis Crick Institute
Co-authored papers 3
Charlie E Massie
University of Cambridge
Co-authored papers 3
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 3
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 3
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 3
Nening Dennis
Institute of Cancer Research
Co-authored papers 3
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
David Jones
Wellcome Sanger Institute
Co-authored papers 3
Hayley C Whitaker
University College London
Co-authored papers 3
Hayley J Luxton
University College London
Co-authored papers 3
Barbara Kremeyer
University College London
Co-authored papers 3
Release 1.2